More GlaxoSmithKline and Unilever excitement awaits…and then onto Taylor Wimpey
Of course I am excited to see GlaxoSmithKline (GSK) shares up nicely today. No surprise, akin to my comments here yesterday, that it has formally told Unilever (ULVR) where to go. Suffice to say there is going to a load of full year number updates from the two names on 9th February (GSK) and 10th February (Unilever), but today’s additional announcement by the former of ‘detailed financial information and future growth ambitions for the new Consumer Healthcare business at a virtual Capital Markets Day for investors and analysts on Monday 28th February 2022’, is really going to be worth a listen to. As noted in my update yesterday I am holding onto my GSK shares. Let’s talk about something else and I see Taylor Wimpey (TW.) is out with its ‘trading statement for the year ended 31 December 2021’ today.
- By Chris Bailey
- 2022-01-17 12:17:10